536 filings
Page 9 of 27
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
30 Apr 20
Unregistered Sales of Equity Securities
4:06pm
4
Chakoutis Peter M
29 Apr 20
Biostage / PETER M CHAKOUTIS ownership change
9:04pm
DEFA14A
HRGN
Harvard Apparatus Regenerative Technology, Inc.
28 Apr 20
Additional proxy soliciting materials
4:51pm
D
HRGN
Harvard Apparatus Regenerative Technology, Inc.
23 Apr 20
$2.18M in equity / options / securities to be acquired, sold $2.18M, 4 investors
4:15pm
SC 13D/A
DST Capital LLC
23 Apr 20
Biostage / DST Capital ownership change
4:15pm
4
HRGN
Harvard Apparatus Regenerative Technology, Inc.
2 Apr 20
Biostage / PETER M CHAKOUTIS ownership change
11:39am
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
27 Mar 20
Biostage Reports 2019 Financial Results
4:11pm
4
Chakoutis Peter M
26 Mar 20
Biostage / PETER M CHAKOUTIS ownership change
6:06pm
3
HRGN
Harvard Apparatus Regenerative Technology, Inc.
26 Mar 20
Biostage / PETER M CHAKOUTIS ownership change
6:03pm
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
24 Mar 20
Departure of Directors or Certain Officers
4:45pm
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
20 Mar 20
Biostage Announces IND Approval from FDA for its Lead Product Candidate Cellspan™ Esophageal Implant
7:05am
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
20 Feb 20
Biostage Submitted Official Response to FDA for Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
4:05pm
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
7 Feb 20
Departure of Directors or Certain Officers
5:00pm
4
DST Capital LLC
6 Feb 20
Change in insider ownership
5:13pm
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
23 Jan 20
Other Events
7:01am
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
2 Jan 20
Biostage Provides Update on FDA Investigational New Drug Application for its Lead Product Candidate Cellspan™ Esophageal Implant
5:11pm
8-K
HRGN
Harvard Apparatus Regenerative Technology, Inc.
18 Dec 19
Entry into a Material Definitive Agreement
4:05pm
SC 13D/A
DST Capital LLC
10 Dec 19
Biostage, Inc.
4:02pm